微创液化治疗高血压壳核出血120例临床分析  

Analysis of Micro-trauma Technique Cooperated with Liquefaction Drainage Treating 120 Patients with Hypertensive Putamen Hemorrhage

作　　者：李洪勤[1] 蒋逢春[1] 王可超 陈永军[1] 毛庆[2] 

机构地区：[1]四川省宣汉县人民医院神经外科,四川宣汉636150 [2]四川大学华西医院神经外科,四川成都610041

出　　处：《华西医学》2009年第5期1230-1232,共3页West China Medical Journal

摘　　要：目的:应用微创液化引流术治疗高血压壳核出血的疗效。方法:对120例高血压壳核出血患者,在CT引导下,依据血肿大小、形态及患者病情,选择适宜的穿刺点、方向,行CT平面导向下微创液化引流术,清除血肿。结果:120例患者出院94例,死亡26例,病死率为21.6%。对存活65例患者随访6个月至2年,以日常生活能力(ADL)评估患者神经功能,ADL128例(43%),ADL220例(30.7%)、ADL310例(15.3%)、ADL45例(7.6%)、ADL52例(3.0%)。结论:应用微创液化引流治疗壳核出血,能最大限度地清除血肿,避免或减轻并发症,具有较大优越性。Objective： To investigate the curative effect of micro-trauma technique cooperated with liquefaction drainage treating the hypertensive putamen hemorrhage. Methods： One hundred patients with hypertensive putamen hemorrhage. With the guidance of CT, choose the proper point of puncture, direction according to the size and type of the hematoma and patient＇s condition, then remove the hematoma with micro-trauma technique cooperated with lique-faction drainage. Results： Ninety-four patients were discharged, 26 patients died, the case fatality rate was 21.6%. Sixty-five survivors were followed up to 2 years, the neuro-function was evaluated by ADL, ADL1 28（43 % ）, ADL2 20 （30.7%）, ADL3 10 （15.3%）, ADL4 5 （7.6%）, ADLs 2 （3.0%）. Conclusion： Micro-trauma technique cooperated with liquefaction drainage treatment for hypertensive putamen hemorrhage can utmost remove the hematoma and avoid or abate the complications.

关 键 词：高血压 壳核出血 引流术 微创 

分 类 号：R651.11[医药卫生—外科学] R544.1[医药卫生—临床医学]